公开(公告)号：US20150322065A1

公开(公告)日：2015-11-12

申请号：US14804644

申请日：2015-07-21

Applicant: Pfizer Inc.

Inventor： Thomas Allen Chappie ,  Patrick Robert Verhoest ,  Nandini Chaturbhai Patel ,  Matthew Merrill Hayward

IPC: C07D471/04

CPC classification number: C07D471/04

Abstract: The present invention is directed to compounds of formula I: or a pharmaceutically acceptable salt thereof, wherein the substituents are as defined herein.

Abstract translation: 本发明涉及式I化合物或其药学上可接受的盐，其中取代基如本文所定义。

公开(公告)号：US20140235612A1

公开(公告)日：2014-08-21

申请号：US14180463

申请日：2014-02-14

Applicant: Pfizer Inc.

Inventor： Thomas Allen Chappie ,  Patrick Robert Verhoest ,  Nandini Chaturbhai Patel ,  Matthew Merrill Hayward

IPC: C07D471/04

CPC classification number: C07D471/04

Abstract: The present invention is directed to compounds of formula I: or a pharmaceutically acceptable salt thereof, wherein the substituents are as defined herein.

Abstract translation: 本发明涉及式I化合物或其药学上可接受的盐，其中取代基如本文所定义。